GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TherapeuticsMD Inc (STU:29TA) » Definitions » E10

TherapeuticsMD (STU:29TA) E10 : €-21.63 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is TherapeuticsMD E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TherapeuticsMD's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.055. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-21.63 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 25.50% per year. During the past 5 years, the average E10 Growth Rate was 39.00% per year. During the past 10 years, the average E10 Growth Rate was 29.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of TherapeuticsMD was 49.90% per year. The lowest was -41.00% per year. And the median was 8.15% per year.

As of today (2024-06-07), TherapeuticsMD's current stock price is €1.86. TherapeuticsMD's E10 for the quarter that ended in Mar. 2024 was €-21.63. TherapeuticsMD's Shiller PE Ratio of today is .


TherapeuticsMD E10 Historical Data

The historical data trend for TherapeuticsMD's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TherapeuticsMD E10 Chart

TherapeuticsMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -142.13 -45.55 -20.79 -22.65 -22.40

TherapeuticsMD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.22 -22.71 -22.04 -22.40 -21.63

Competitive Comparison of TherapeuticsMD's E10

For the Drug Manufacturers - Specialty & Generic subindustry, TherapeuticsMD's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TherapeuticsMD's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TherapeuticsMD's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TherapeuticsMD's Shiller PE Ratio falls into.



TherapeuticsMD E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TherapeuticsMD's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.055/131.7762*131.7762
=-0.055

Current CPI (Mar. 2024) = 131.7762.

TherapeuticsMD Quarterly Data

per share eps CPI Adj_EPS
201406 -2.576 100.560 -3.376
201409 -4.656 100.428 -6.109
201412 -4.055 99.070 -5.394
201503 -6.006 99.621 -7.945
201506 -7.128 100.684 -9.329
201509 -4.900 100.392 -6.432
201512 -4.590 99.792 -6.061
201603 -4.939 100.470 -6.478
201606 -4.895 101.688 -6.343
201609 -5.791 101.861 -7.492
201612 -5.688 101.863 -7.358
201703 -5.142 102.862 -6.587
201706 -4.450 103.349 -5.674
201709 -2.937 104.136 -3.717
201712 -4.225 104.011 -5.353
201803 -4.460 105.290 -5.582
201806 -6.420 106.317 -7.957
201809 -6.856 106.507 -8.483
201812 -7.471 105.998 -9.288
201903 -7.080 107.251 -8.699
201906 -10.178 108.070 -12.411
201909 -5.902 108.329 -7.179
201912 -8.550 108.420 -10.392
202003 -9.502 108.902 -11.498
202006 -8.436 108.767 -10.221
202009 -5.094 109.815 -6.113
202012 -6.165 109.897 -7.392
202103 -4.763 111.754 -5.616
202106 -4.490 114.631 -5.162
202109 -4.777 115.734 -5.439
202112 -4.425 117.630 -4.957
202203 -5.176 121.301 -5.623
202206 12.137 125.017 12.793
202209 -3.161 125.227 -3.326
202212 7.646 125.222 8.046
202303 -0.346 127.348 -0.358
202306 -0.222 128.729 -0.227
202309 -0.300 129.860 -0.304
202312 -0.055 129.419 -0.056
202403 -0.055 131.776 -0.055

Add all the adjusted EPS together and divide 10 will get our e10.


TherapeuticsMD  (STU:29TA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


TherapeuticsMD E10 Related Terms

Thank you for viewing the detailed overview of TherapeuticsMD's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


TherapeuticsMD (STU:29TA) Business Description

Traded in Other Exchanges
Address
951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

TherapeuticsMD (STU:29TA) Headlines

No Headlines